Related Experiment Video
Updated: May 25, 2026
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Tumor detection strategy using ZnO light-emitting nanoprobes
Sheng-Chieh Yang1, Yi-Chun Shen, Tzu-Chun Lu
1Graduate Institute of Photonics and Optoelectronics, National Taiwan University, 1 Roosevelt Road, Section 4, Taipei 106, Taiwan.
Nanotechnology
|January 13, 2012
Summary
This study introduces novel ZnO nanorods bonded to antibodies for detecting cancer cells, offering a new method for real-time identification during surgery. The probes emit purple light, enabling clear visualization of tumors with high epidermal growth factor receptor (EGFR) expression.
Area of Science:
- Biotechnology
- Nanomedicine
- Oncology
Background:
- Traditional cancer cell detection methods like fluorescence have limitations during tumor resection.
- Accurate identification of cancer cells during surgery is crucial for effective treatment.
Purpose of the Study:
- To develop and evaluate a novel tumor detection technology using ZnO nanorods bonded to antibodies.
- To enable real-time, naked-eye or microscope-assisted identification of cancer cells during tumor resection.
Main Methods:
- Antibodies targeting epidermal growth factor receptor (EGFR) were conjugated to ZnO nanorods.
- The ZnO/EGFR antibody probes were applied to squamous cell carcinoma (SCC) cells and Hs68 cells (with lower EGFR expression).
- Detection was based on purple light emission from ZnO nanorods upon binding to EGFR and analysis of photoluminescent spectra.
Main Results:
- ZnO/EGFR antibody probes successfully identified SCC cells expressing EGFR via purple light emission.
- No purple light was observed for Hs68 cells with lower EGFR expression, indicating probe specificity.
- Photoluminescent spectra showed a significantly higher intensity ratio of purple light (ZnO) to green light (autofluorescence) in SCC compared to Hs68 cells.
Conclusions:
- ZnO nanorods conjugated with EGFR antibodies offer a promising tool for real-time cancer cell identification.
- This technology has potential applications in surgical settings for precise tumor excision.
- The method provides a visual marker for distinguishing cancer cells based on EGFR expression levels.
